Literature DB >> 28778694

Minimally invasive aortic arch surgery: Early and late outcomes.

Petar Risteski1, Ali El-Sayed Ahmad2, Nadejda Monsefi2, Nestoras Papadopoulos2, Isabel Radacki2, Eva Herrmann3, Anton Moritz2, Andreas Zierer2.   

Abstract

BACKGROUND: We analyzed our experience with the aortic arch operations performed through a minimally invasive approach, with emphasis on safety and feasibility, early and late outcomes.
MATERIAL AND METHODS: We reviewed the medical records of 71 adult patients with aortic arch aneurysm (58, 82%), dissection (10, 14%) or porcelain aorta (3, 4%) who underwent primary arch surgery through a partial upper sternotomy.
RESULTS: The aortic arch was replaced partially in 45 (63%), or totally in 26 (37%) patients. The repair was further extended with the elephant trunk procedure, conventional in 8 (11.3%) or frozen in 15 (21.1%) patients. No conversion to full sternotomy was needed. New permanent renal failure occurred in 1 (1.4%), temporary neurologic deficit in 2 (2.8%) and permanent neurologic deficit in 3 (4.2%) patients. Early mortality was observed in 4 (5.6%) patients. Actuarial survival was 79.2 ± 8.3% at 4 years and cumulative reoperation-free survival was 76.4 ± 9.4% at 4 years.
CONCLUSION: Minimally invasive aortic arch surgery is safe and feasible. Early outcomes are at the lower range compared to other published series. Late outcomes are not adversely influenced, as the desired extent of aortic resection can be achieved, producing a durable aortic repair.
Copyright © 2017 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aorta; Aortic arch; Minimally invasive aortic surgery; Moderate hypothermia

Mesh:

Year:  2017        PMID: 28778694     DOI: 10.1016/j.ijsu.2017.07.105

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  1 in total

1.  Commentary: The mini-Bentall approach: Small and safe!

Authors:  Manfred Richter; Oliver J Liakopoulos
Journal:  JTCVS Tech       Date:  2021-03-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.